Cargando…

Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification

INTRODUCTION: Low or undetectable plasma viral load (VL) using current qPCR assays is common for HIV-2 patients. Digital PCR is an emerging technology enabling more precision and reproducibility than qPCR at low DNA/RNA copy numbers. Available data related to digital droplet PCR (ddPCR, Bio-Rad) und...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruelle, Jean, Yfantis, Vasilieios, Duquenne, Armelle, Goubau, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225411/
https://www.ncbi.nlm.nih.gov/pubmed/25397425
http://dx.doi.org/10.7448/IAS.17.4.19675
_version_ 1782343501046874112
author Ruelle, Jean
Yfantis, Vasilieios
Duquenne, Armelle
Goubau, Patrick
author_facet Ruelle, Jean
Yfantis, Vasilieios
Duquenne, Armelle
Goubau, Patrick
author_sort Ruelle, Jean
collection PubMed
description INTRODUCTION: Low or undetectable plasma viral load (VL) using current qPCR assays is common for HIV-2 patients. Digital PCR is an emerging technology enabling more precision and reproducibility than qPCR at low DNA/RNA copy numbers. Available data related to digital droplet PCR (ddPCR, Bio-Rad) underscore issues linked to the threshold definition of positivity, coupled to the specificity of low copy results [1]. MATERIALS AND METHODS: A RT-PCR protocol was set up using the One-Step RT-ddPCR Kit for Probes on the QX200 platform (Bio-Rad, Hercules, CA) in an accredited environment (ISO15189:2012 norm). Parameters tested were in line with the digital MIQE guidelines [2]. Inter-run coefficient of variation (CV) was established using synthetic RNA controls diluted in HIV-negative plasma. The ddPCR assay was compared to a qRT-PCR previously used in routine (LOQ 50 cop/mL [3]) using 46 clinical samples and the NIBSC international HIV-2 RNA standard. RESULTS: The optimal PCR efficiency and the best separation between positive and negative droplets were obtained with a mixture containing 0.5 mM manganese acetate, 700 nM primers and 250 nM of the 5'FAM-probe. Using a manual threshold to define positivity, 7.74% of negative controls (n=168) were scored as positive due to one positive droplet. The presence of two positive droplets or more was not observed for negative controls. Serial dilutions of a positive control showed excellent linearity (R2=0.999) and enabled us to define a limit of quantification of two positives droplets, which corresponds to 0.14 copies/μL in the reaction mixture and to seven copies per mL of plasma. The inter-run coefficient of variation was 3.37% at a mean value of 4,468 cop/mL, 19.59% at 416 cop/mL and 32.28% at 8 cop/mL. The NIBSC standard of 1,000 IU was quantified 1,400 copies by ddPCR and close to 5,000 copies by qPCR (delta log superior to 0.5). Among 46 clinical samples, 22 were undetectable with both qPCR and ddPCR, 12 were detected with both methods (respective means of 10,612 and 2,224 cop/mL, delta log=0.68) and 12 others were quantified by ddPCR only below 50 cop/mL (mean=16 cop/mL). CONCLUSIONS: We validated a ddPCR HIV-2 VL assay that is more sensitive and more reproducible than the qPCR assay used as comparator, with a limit of quantification of 7 cop/mL of plasma. A careful definition of the limit of blank allows the management of false positive droplets, but the variable user-defined positive threshold may be an issue for compliance to the quality norms.
format Online
Article
Text
id pubmed-4225411
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-42254112014-11-13 Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification Ruelle, Jean Yfantis, Vasilieios Duquenne, Armelle Goubau, Patrick J Int AIDS Soc Poster Sessions – Abstract P143 INTRODUCTION: Low or undetectable plasma viral load (VL) using current qPCR assays is common for HIV-2 patients. Digital PCR is an emerging technology enabling more precision and reproducibility than qPCR at low DNA/RNA copy numbers. Available data related to digital droplet PCR (ddPCR, Bio-Rad) underscore issues linked to the threshold definition of positivity, coupled to the specificity of low copy results [1]. MATERIALS AND METHODS: A RT-PCR protocol was set up using the One-Step RT-ddPCR Kit for Probes on the QX200 platform (Bio-Rad, Hercules, CA) in an accredited environment (ISO15189:2012 norm). Parameters tested were in line with the digital MIQE guidelines [2]. Inter-run coefficient of variation (CV) was established using synthetic RNA controls diluted in HIV-negative plasma. The ddPCR assay was compared to a qRT-PCR previously used in routine (LOQ 50 cop/mL [3]) using 46 clinical samples and the NIBSC international HIV-2 RNA standard. RESULTS: The optimal PCR efficiency and the best separation between positive and negative droplets were obtained with a mixture containing 0.5 mM manganese acetate, 700 nM primers and 250 nM of the 5'FAM-probe. Using a manual threshold to define positivity, 7.74% of negative controls (n=168) were scored as positive due to one positive droplet. The presence of two positive droplets or more was not observed for negative controls. Serial dilutions of a positive control showed excellent linearity (R2=0.999) and enabled us to define a limit of quantification of two positives droplets, which corresponds to 0.14 copies/μL in the reaction mixture and to seven copies per mL of plasma. The inter-run coefficient of variation was 3.37% at a mean value of 4,468 cop/mL, 19.59% at 416 cop/mL and 32.28% at 8 cop/mL. The NIBSC standard of 1,000 IU was quantified 1,400 copies by ddPCR and close to 5,000 copies by qPCR (delta log superior to 0.5). Among 46 clinical samples, 22 were undetectable with both qPCR and ddPCR, 12 were detected with both methods (respective means of 10,612 and 2,224 cop/mL, delta log=0.68) and 12 others were quantified by ddPCR only below 50 cop/mL (mean=16 cop/mL). CONCLUSIONS: We validated a ddPCR HIV-2 VL assay that is more sensitive and more reproducible than the qPCR assay used as comparator, with a limit of quantification of 7 cop/mL of plasma. A careful definition of the limit of blank allows the management of false positive droplets, but the variable user-defined positive threshold may be an issue for compliance to the quality norms. International AIDS Society 2014-11-02 /pmc/articles/PMC4225411/ /pubmed/25397425 http://dx.doi.org/10.7448/IAS.17.4.19675 Text en © 2014 Ruelle J et al; licensee International AIDS Society http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Sessions – Abstract P143
Ruelle, Jean
Yfantis, Vasilieios
Duquenne, Armelle
Goubau, Patrick
Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification
title Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification
title_full Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification
title_fullStr Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification
title_full_unstemmed Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification
title_short Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification
title_sort validation of an ultrasensitive digital droplet pcr assay for hiv-2 plasma rna quantification
topic Poster Sessions – Abstract P143
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225411/
https://www.ncbi.nlm.nih.gov/pubmed/25397425
http://dx.doi.org/10.7448/IAS.17.4.19675
work_keys_str_mv AT ruellejean validationofanultrasensitivedigitaldropletpcrassayforhiv2plasmarnaquantification
AT yfantisvasilieios validationofanultrasensitivedigitaldropletpcrassayforhiv2plasmarnaquantification
AT duquennearmelle validationofanultrasensitivedigitaldropletpcrassayforhiv2plasmarnaquantification
AT goubaupatrick validationofanultrasensitivedigitaldropletpcrassayforhiv2plasmarnaquantification